{"id":"NCT04382326","sponsor":"Pfizer","briefTitle":"20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants","officialTitle":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-05-20","primaryCompletion":"2022-09-02","completion":"2022-09-02","firstPosted":"2020-05-11","resultsPosted":"2023-12-06","lastUpdate":"2023-12-06"},"enrollment":1997,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"20-valent pneumococcal conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine","otherNames":[]}],"arms":[{"label":"20-valent pneumococcal conjugate vaccine","type":"EXPERIMENTAL"},{"label":"13-valent pneumococcal conjugate vaccine","type":"ACTIVE_COMPARATOR"}],"summary":"20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants","primaryOutcome":{"measure":"Percentage of Participants With Local Reactions Within 7 Days After Dose 1","timeFrame":"Within 7 days after Dose 1","effectByArm":[{"arm":"20vPnC","deltaMin":25.5,"sd":null},{"arm":"13vPnC","deltaMin":24.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":110,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["38535409","37846456"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B7471011"]},"adverseEventsSummary":{"seriousAny":{"events":45,"n":1001},"commonTop":["Irritability (IRRITABILITY)","Hypersomnia (INCREASED SLEEP)","Injection site pain (PAIN)","Decreased appetite (DECREASED APPETITE)","Injection site erythema (REDNESS)"]}}